Trump CBD reimbursement program stalls ahead of federal hemp ban

The Quick Take
The looming federal hemp ban is discouraging healthcare organizations from participating in a Trump administration effort to offer reimbursements for hemp-derived CBD products. And hemp companies aren't reporting revenue. Trump CBD reimbursement program stalls ahead of federal hemp ban is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to MJBizDaily.



